Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Lung Cancer

Free Subscription 02.03.2026 2 AJR Am J Roentgenol 1 Am J Epidemiol 2 Am J Respir Cell Mol Biol 4 Am J Respir Crit Care Med 1 Ann Surg Oncol 2 Ann Thorac Surg 2 Anticancer Res 1 Arch Bronconeumol 3 BMC Cancer 2 Cancer Lett 1 Cancer Sci 8 Clin Lung Cancer 1 Eur J Cancer 3 Eur J Cardiothorac Surg 1 Int J Cancer 2 Int J Radiat Oncol Biol Phys 2 J Thorac Cardiovasc Surg 2 J Thorac Oncol 1 Lancet Oncol 3 Lung Cancer 1 Lung Cancer (Auckl) 1 Oncogene 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJR Am J Roentgenol

1. HONG EK, Leung A
   Artificial Intelligence-Assisted Diagnosis of Pulmonary Nodules in Lung Cancer Screening: Counterpoint-False Positives, Workflow Disruption, and the Enduring Role of Radiologists.
   AJR Am J Roentgenol. 2026 Feb 25. doi: 10.2214/AJR.26.34524.
   PubMed        
   
   
2. YANKELEVITZ DF, Yip R
   Artificial Intelligence-Assisted Diagnosis of Pulmonary Nodules in Lung Cancer Screening: Point-An Evolving Capability That Will Strengthen Screening Practice.
   AJR Am J Roentgenol. 2026 Feb 25. doi: 10.2214/AJR.26.34718.
   PubMed        
   
   

   
   Am J Epidemiol

3. KESSLER LG, Comstock B, Aiello Bowles EJ, Mou J, et al
   Measuring the Validity of Survey Questions on Breast, Cervical, Colorectal, and Lung Cancer Screening.
   Am J Epidemiol. 2026 Feb 27:kwag040. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Am J Respir Cell Mol Biol

4. MUKHITOV AR, Evans JF, Han T, Ledwell OA, et al
   Extracellular Matrix and Fibroblast Activation in Lymphangioleiomyomatosis.
   Am J Respir Cell Mol Biol. 2026;74:257-270.
   PubMed         Abstract available
   
   
5. LI Y, Zhou L, Li H, Sun G, et al
   Long-Read Sequencing Reveals Tumor-Specific Splicing Isoforms as Therapeutic Targets in Non-Small-Cell Lung Cancer.
   Am J Respir Cell Mol Biol. 2026;74:167-176.
   PubMed         Abstract available
   
   

   
   Am J Respir Crit Care Med

6. GHOLAMI M, Vaezi A, Firouzi A, Banoei MM, et al
   Microplastic Accumulation in the Human Lung: Distinct Signatures in Lung Cancer vs Normal Tissue.
   Am J Respir Crit Care Med. 2026 Feb 21:aamag081. doi: 10.1093.
   PubMed        
   
   
7. KASHIZAKI F, Oouchi M, Watanabe S, Shonai S, et al
   Lung Cancer with MET Exon 14 Skipping Mutation Presenting with a Crazy-Paving Appearance.
   Am J Respir Crit Care Med. 2026 Feb 15:aamag036. doi: 10.1093.
   PubMed        
   
   
8. XIE N, Xu X, Wang Y, Wang A, et al
   A trans-omics gene-smoking interaction study of lung cancer based on consortium data.
   Am J Respir Crit Care Med. 2026 Jan 23:aamaf097. doi: 10.1093.
   PubMed         Abstract available
   
   
9. PENG F, Wang S, Jiao H, Dang M, et al
   Accurate and early diagnosis of non-small cell lung cancer using aberrant fragmentomic features of circulating cell-free mitochondrial DNA.
   Am J Respir Crit Care Med. 2026;212:105-116.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

10. TANE S, Nishikubo M, Manabe T, Watanabe T, et al
    Efficacy and Safety of Salvage Surgery After Immunotherapy in Non-small Cell Lung Cancer: A Multi-institutional Retrospective Study.
    Ann Surg Oncol. 2026 Feb 26. doi: 10.1245/s10434-026-19283.
    PubMed         Abstract available
    
    

    
    Ann Thorac Surg

11. ZHAN PL, Canavan ME, Bader JM, Boffa DJ, et al
    Prolonged Survival in Mesothelioma Patients Without Surgical Resection: A National Cancer Database Analysis.
    Ann Thorac Surg. 2026;121:633-642.
    PubMed         Abstract available
    
    
12. KITAZAWA S, Bernards N, Sata Y, Yokote F, et al
    INTRAOPERATIVE SURGICAL MARGIN ASSESSMENT OF SUBLOBAR LUNG RESECTION SPECIMENS USING COMPUTED TOMOGRAPHY.
    Ann Thorac Surg. 2025 Jun 23:S0003-4975(25)00546.
    PubMed         Abstract available
    
    

    
    Anticancer Res

13. SANGSEEKEW W, Boonsombat J, Thongnest S, Sirirak J, et al
    Mechanistic Studies of Anticancer Effects of Salicylaldehyde Benzoylhydrazone in 2D/3D Lung Cancer Cell Cultures.
    Anticancer Res. 2026;46:1365-1387.
    PubMed         Abstract available
    
    
14. YU NN, Liu Y, Guo XY, Kim KK, et al
    CD133(+) Lung Cancer Stem-like Cells Resist Plasma-activated Medium Through PRDX5-mediated Antioxidant Defense.
    Anticancer Res. 2026;46:1293-1306.
    PubMed         Abstract available
    
    

    
    Arch Bronconeumol

15. GOROSPE-SARASUA L, Martin-Pinacho JJ, Arrieta P
    The Renewed Role of Interventional Thoracic Radiology in TNM-9 Staging of Left Upper Lobe Lung Cancer With Ipsilateral Mediastinal Involvement Inaccessible to Endobronchial Ultrasound.
    Arch Bronconeumol. 2026 Feb 15:S0300-2896(26)00073.
    PubMed        
    
    

    
    BMC Cancer

16. WHITE LL, Maiyani M, Quintana LM, Powers JD, et al
    Use of cell-free DNA in early detection of lung cancer: a proof-of concept study.
    BMC Cancer. 2026 Feb 25. doi: 10.1186/s12885-026-15790.
    PubMed        
    
    
17. NAJAH Q, Makhlouf HA, Osman ASA, Almosilhy NA, et al
    Efficacy and tolerability of first-line treatment regimens for extensive-stage small cell lung cancer - a grade-assessed network meta-analysis of randomized controlled trials.
    BMC Cancer. 2026 Feb 27. doi: 10.1186/s12885-025-15439.
    PubMed        
    
    
18. QIAN H, Jiang J, Li S, Ni C, et al
    Efficacy and safety of nab-paclitaxel plus PD-1 inhibitor in elderly patients with advanced squamous lung cancer.
    BMC Cancer. 2026 Feb 21. doi: 10.1186/s12885-026-15767.
    PubMed        
    
    

    
    Cancer Lett

19. YANG J, Zhang M, Gao C, Yao X, et al
    The Histone-Modified Landscape: Core Mechanisms of Osimertinib Resistance in EGFR-Mutant Lung Cancer.
    Cancer Lett. 2026 Feb 19:218321. doi: 10.1016/j.canlet.2026.218321.
    PubMed         Abstract available
    
    
20. CHEN Y, Xing H, Yang X, Shen J, et al
    Patient-derived malignant effusion organoids guide tailored therapy and dissect third-generation EGFR-tyrosine kinase inhibitor resistance mechanisms in lung cancer.
    Cancer Lett. 2026;645:218356.
    PubMed         Abstract available
    
    

    
    Cancer Sci

21. KURIBAYASHI T, Nishimura J, Okawa S, Taoka M, et al
    TGF-beta Inhibitor Potentiates Osimertinib-Induced Anti-Tumor Immunity in Egfr-Mutant Lung Cancer.
    Cancer Sci. 2026 Feb 27. doi: 10.1111/cas.70352.
    PubMed         Abstract available
    
    

    
    Clin Lung Cancer

22. JINBO M, Cheng L, Xiao W, Pengfei Z, et al
    Thoracic Radiotherapy and Radiation Time Would Affect the Efficacy of Advanced Non-Small Cell Lung Cancer for Patients Who Responded to TKIs Treatment.
    Clin Lung Cancer. 2026;27:126-134.
    PubMed         Abstract available
    
    
23. KIM D, Blocker S, Cavalieri CC, Cannon S, et al
    Outcomes of Concurrent Radiotherapy With Tarlatamab in Extensive-Stage Small Cell Lung Cancer From the DLL3 PanTUMOR Database.
    Clin Lung Cancer. 2026 Jan 30:S1525-7304(26)00017.
    PubMed         Abstract available
    
    
24. PAZ-ARES LG, O'Byrne KJ, Johnson ML, Reck M, et al
    TIGOS Trial: A Randomized, Double-Blind, Phase III Trial of Atigotatug and Nivolumab Fixed-Dose Combination With Chemotherapy Versus Atezolizumab With Chemotherapy as First-Line Therapy in Patients With Extensive-Stage Small Cell Lung Cancer.
    Clin Lung Cancer. 2026;27:140-145.
    PubMed         Abstract available
    
    
25. MOUNTZIOS G, Weng JK, Zairi E, Hsieh K, et al
    Characterizing Risk Factors and Outcomes in Patients With Unresectable, Stage III Non-Small-Cell Lung Cancer Who Do Not Complete, or Who Experience Progression During/Within 42 Days of, Concurrent Chemoradiotherapy: The POSITION Study.
    Clin Lung Cancer. 2026 Jan 19:S1525-7304(26)00015.
    PubMed         Abstract available
    
    
26. PEREZ C, Krishna V, Bolster D, Knabe K, et al
    Factors Influencing Refusal of Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma.
    Clin Lung Cancer. 2026;27:108-116.
    PubMed         Abstract available
    
    
27. MORINAGA D, Furuta M, Fukui D, Matsuura Y, et al
    Amivantamab-Associated Vasculitis in a Patient With EGFR Exon 20 Insertion Non-Small Cell Lung Cancer: A Case Report.
    Clin Lung Cancer. 2026;27:117-120.
    PubMed        
    
    
28. ZHAI X, Liang Z, Zhen C, Zhai N, et al
    First Frameshift Mutation of ALK in Non-Small Cell Lung Cancer Remaining Sensitive to Alectinib: Case Report.
    Clin Lung Cancer. 2026 Jan 20:S1525-7304(26)00014.
    PubMed        
    
    
29. MORINAGA D, Kitai H, Sato H, Fukui D, et al
    Limited-Stage Small-Cell Lung Cancer With Severe Paraneoplastic Limbic Encephalitis Successfully Treated With Chemoradiotherapy Followed by Immune Checkpoint Inhibitor Maintenance Therapy: A Case Report.
    Clin Lung Cancer. 2026;27:121-125.
    PubMed        
    
    

    
    Eur J Cancer

30. GEMELLI M, Sala L, Morabito A, Sforza V, et al
    Real-world outcomes of immunotherapy discontinuation at two years in advanced non-small cell lung cancer: Final results of the I-STOP study.
    Eur J Cancer. 2026;237:116579.
    PubMed         Abstract available
    
    

    
    Eur J Cardiothorac Surg

31. STORK T, Adamkova D, Aigner C, Bravio I, et al
    How Should Primary Pulmonary Sarcoma be Staged? Results of an International Multicentre Analysis.
    Eur J Cardiothorac Surg. 2026;68:ezag020.
    PubMed         Abstract available
    
    
32. BERJAOUI N, Fabbri G, Lampridis S, Maraschi A, et al
    Does robotic segmentectomy improve long-term outcomes in non-small cell lung cancer?
    Eur J Cardiothorac Surg. 2026 Jan 28:ezag048. doi: 10.1093.
    PubMed         Abstract available
    
    
33. MARTINEZ-HERNANDEZ NJ, Cabanero-Sanchez A, Corcoles-Padilla JM, Chacon-Del Pino E, et al
    Standardized Recommendations for the Implementation of Enhanced Recovery Protocols in Thoracic Surgery in Spain: A Delphi Consensus Study.
    Eur J Cardiothorac Surg. 2026;68:ezag083.
    PubMed         Abstract available
    
    

    
    Int J Cancer

34. TIAN Z, Dai S, Yang X, Zou B, et al
    Thoracic radiotherapy synergizes with first-line EGFR-TKIs in advanced EGFR-mutant NSCLC: A dual-center real-world study.
    Int J Cancer. 2026;158:2168-2178.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

35. BARRETT S, Zahid M, McGarry CK, Enderling H, et al
    External Validation of The Proliferation Saturation Index Model in Predicting Tumour Volume Regression in Patients with Non-Small Cell Lung Cancer Undergoing Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2026 Feb 20:S0360-3016(26)00399.
    PubMed         Abstract available
    
    
36. ADIB E, Willers H, Samson PP, Robinson CG, et al
    Integration of Immune Checkpoint Blockade With Radiation in Lung Cancer: Lessons From Recent Trials.
    Int J Radiat Oncol Biol Phys. 2026;124:887-891.
    PubMed        
    
    

    
    J Thorac Cardiovasc Surg

37. JIN H, Zu P, Liu W
    Statistical and anatomical refinements for spread-through-air-spaces-positive non-small cell lung cancer resection analysis.
    J Thorac Cardiovasc Surg. 2026 Feb 22:S0022-5223(26)00088.
    PubMed        
    
    
38. GHEZELJEH TN, Cho AR, Guigui A, Douglas L, et al
    Cost Evaluation of a Multimodal Prehabilitation Program for High-risk Lung Cancer Surgery.
    J Thorac Cardiovasc Surg. 2026 Feb 25:S0022-5223(26)00168.
    PubMed         Abstract available
    
    

    
    J Thorac Oncol

39. ILLINI O, Hund AC, Kopp HG, Moskovitz M, et al
    Systemic and Intracranial Efficacy and Safety of Trastuzumab Deruxtecan in Patients with HER2-Mutant Non-Small Cell Lung Cancer across Treatment Lines: Evidence from the TRACER/HERTras Real-World Cohort.
    J Thorac Oncol. 2026 Feb 24:103651. doi: 10.1016/j.jtho.2026.103651.
    PubMed         Abstract available
    
    
40. GULDBRANDSEN KF, Bloch M, Skougaard K, Ahlborn LB, et al
    Corrigendum to 'Surveillance With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography of Patients With Stage I-to-III Lung Cancer After Completion of Curative treatment (SUPE_R): A Randomized Controlled Trial' [Journal of T
    J Thorac Oncol. 2026 Feb 24:103558. doi: 10.1016/j.jtho.2026.103558.
    PubMed        
    
    

    
    Lancet Oncol

41. GOURD E
    FDA fast-tracks first inhalable gene therapy for lung cancer.
    Lancet Oncol. 2026 Feb 19:S1470-2045(26)00083.
    PubMed        
    
    

    
    Lung Cancer

42. STENSLAND EM, Stensgaard S, Eide IJZ, Nilssen Y, et al
    Upfront treatment with osimertinib in lung cancer patients with and without active brain metastases, and the role of ctDNA as a biomarker; a phase II clinical trial (the FIOL study).
    Lung Cancer. 2026;214:109338.
    PubMed         Abstract available
    
    
43. KINEHARA Y, Matsumoto K, Shiroyama T, Komuta K, et al
    Comparison of long-term survival between nivolumab plus ipilimumab with chemotherapy and pembrolizumab with chemotherapy in advanced non-small cell lung cancer: A multicenter retrospective cohort study.
    Lung Cancer. 2026;214:109336.
    PubMed         Abstract available
    
    
44. NICOS M, Stokowy T, Reszka K, Kowalczyk A, et al
    Mutational landscapes of brain metastases across various histological subtypes of lung cancer.
    Lung Cancer. 2026;214:109342.
    PubMed         Abstract available
    
    

    
    Lung Cancer (Auckl)

45. ZHOU J, Wang Y, Peng J, Tang KJ, et al
    Prospective Observational Real-World Study of Afatinib as First-Line Treatment in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) in China.
    Lung Cancer (Auckl). 2026;17:555262.
    PubMed         Abstract available
    
    

    
    Oncogene

46. LAPEYRONNIE E, Granet C, Tricard J, Gallet F, et al
    Sortilin exhibits tumor suppressor-like activity by limiting EGFR transduction function.
    Oncogene. 2026;45:875-888.
    PubMed         Abstract available
    
    

    
    PLoS One

47. XIANG AP, Yuan XF, Qin ZQ
    Survival study of cytoreductive prostatectomy for prostate cancer with lung metastasis: A propensity score matching study based on the SEER database.
    PLoS One. 2026;21:e0342758.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum